Women with thrombophilia and a history of recurrent pregnancy loss have poor pregnancy outcomes. Prophylaxis with enoxaparin 40 mg/day or 80 mg/day resulted in favorable gestational and neonatal outcomes. ©2005 by American Society for Reproductive Medicine.
B., B., J., B., M., E., I., Y., D., Y., & A., S. (2005). Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: Results from the Live-Enox study. Fertility and Sterility. B. Brenner, Thrombosis and Hemostasis Unit, Rambam Medical Center, PO Box 9602, Haifa 31096, Israel. E-mail: email@example.com: Elsevier Inc. Retrieved from http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed7&NEWS=N&AN=2005418658